Skip to main content
Equibles

Legal & General Group Plc

Position in PRLD — Prelude Therapeutics Inc

CIK 764068 London, X0
Back to PRLD Full portfolio

Position in PRLD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,385
+$13,647 QoQ
Shares Held
2,699
+180.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 75 holders
Holding Since
Sep 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. PRLD ranks #267 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in PRLD

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,385 2,699
2025-03-31 $738 962
2024-12-31 $1,226 962
2024-09-30 $1,991 962
2024-06-30 $3,665 962
2024-03-31 $4,559 962
2023-12-31 $4,107 962
2023-09-30 $2,972 962
2023-06-30 $4,329 962
2022-03-31 $27,006 3,914
2021-12-31 $48,729 3,914
2021-09-30 $92,437 2,958
2021-06-30 $31,979 1,117
2021-03-31 $45,409 1,048
2020-12-31 $71,836 1,004
2020-09-30 $1,852,663 61,489